Response to Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154
Diabetes Care
.
2020 Jan;43(1):e11.
doi: 10.2337/dci19-0058.
Authors
Beckey Trinh
1
,
Marc Y Donath
2
3
,
Heinz Läubli
3
4
Affiliations
1
Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland beckey.trinh@usb.ch.
2
Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
3
Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
4
Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
PMID:
31862827
DOI:
10.2337/dci19-0058
No abstract available
Publication types
Letter
Comment